Seaport Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	52.91	46.04	309.1
Short-Term Investments	129.7	169.94	-
Cash & Short-Term Investments	182.61	215.98	309.1
Cash Growth	-40.92%	-30.13%	-
Other Current Assets	5.74	7.25	1.05
Total Current Assets	188.34	223.23	310.15
Net Property, Plant & Equipment	5.45	5.23	5.17
Long-Term Investments	30.04	17.67	-
Other Long-Term Assets	3.84	2.88	0.45
Total Assets	227.67	249.01	315.78
Accounts Payable	4.8	2.01	5.08
Accrued Expenses	7.83	9.13	5.21
Current Portion of Leases	1.6	1.64	0.86
Total Current Liabilities	14.22	12.78	11.15
Long-Term Leases	3.74	3.44	4.15
Total Long-Term Liabilities	3.74	3.44	4.15
Total Liabilities	17.97	16.23	15.3
Common Stock	0	0	0
Additional Paid-in Capital	23.83	21.26	14.38
Accumulated Other Comprehensive Income	0.06	0.3	-
Retained Earnings	-139.52	-114.11	-39.23
Total Common Shareholders' Equity	-115.62	-92.55	-24.85
Minority Interest	325.33	325.33	325.33
Shareholders' Equity	209.71	232.78	300.48
Total Liabilities & Equity	227.67	249.01	315.78

SEC Filings: 10-K · 10-Q